Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Industriels
  2. Médicament
  3. BENEMIDE (probénécide)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

BENEMIDE (probénécide)

Medicine - Posted on Nov 07 2016 - Updated on Jun 12 2019
Active substance (DCI)
  • probénécide
history (4)
  • 10/19/16

    BENEMIDE (probénécide)

    Avis défavorable au maintien du remboursement dans le traitement adjuvant de la pénicillinothérapie ...
    icône flèche
  • 9/23/15

    BENEMIDE (probénécide)

    Maintien du remboursement dans les mêmes conditions
    icône flèche
  • 9/8/10

    BENEMIDE (probénécide)

    BENEMIDE (probénécide)
    icône flèche
  • 11/16/05

    BENEMIDE 500 mg, comprimé sécable 30 comprimés (CIP : 301 048-2)

    BENEMIDE 500 mg, comprimé sécable 30 comprimés (CIP : 301 048-2)
    icône flèche
Technical information
ATC code
  • M04AB01
Manufacturer
BOUCHARA RECORDATI
Presentation

BENEMIDE 500 mg, comprimé sécable (code CIS : 69639623) 3 plaquette(s) thermoformée(s) PVC aluminium de 10 comprimé(s) - Code CIP : 3400930104828

All our publications
    Congenital, genetic and rare diseases Drug therapy Joint and rheumatic diseases Metabolic diseases

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
BFgmQ5CDDLpQ0uND